Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antiphospholipid syndrome: clinical and therapeutic aspects.
Vlachoyiannopoulos PG, Tsiakou E, Chalevelakis G, Raptis SA, Moutsopoulos HM. Vlachoyiannopoulos PG, et al. Lupus. 1994 Apr;3(2):91-6. doi: 10.1177/096120339400300206. Lupus. 1994. PMID: 7920620
Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial.
Avgerinos A, Armonis A, Manolakopoulos S, Rekoumis G, Argirakis G, Viazis N, Vlachogiannakos J, Adamopoulos A, Kanaghinis T, Raptis SA. Avgerinos A, et al. Gastrointest Endosc. 2000 Jun;51(6):652-8. doi: 10.1067/mge.2000.105983. Gastrointest Endosc. 2000. PMID: 10840295 Clinical Trial.
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
Dervenoulas J, Tsirigotis P, Bollas G, Pappa V, Xiros N, Economopoulos T, Pappa M, Mellou S, Kostourou A, Papageorgiou E, Raptis SA. Dervenoulas J, et al. Ann Hematol. 2000 Feb;79(2):66-72. doi: 10.1007/s002770050012. Ann Hematol. 2000. PMID: 10741917
Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide.
Raptis AE, Tountas N, Yalouris AG, Hadjidakis D, Zaharis A, Miras K, Raptis SA. Raptis AE, et al. Acta Diabetol Lat. 1990 Jan-Mar;27(1):11-22. doi: 10.1007/BF02624718. Acta Diabetol Lat. 1990. PMID: 2110711
Proinsulin as a possible therapeutic agent.
Hadjidakis DJ, Raptis SA. Hadjidakis DJ, et al. Horm Metab Res Suppl. 1992;26:131-7. Horm Metab Res Suppl. 1992. PMID: 1490681 Review.
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.
Pectasides D, Pectasides M, Farmakis D, Gaglia A, Koumarianou A, Nikolaou M, Koumpou M, Kountourakis P, Papaxoinis G, Mitrou P, Economopoulos T, Raptis SA. Pectasides D, et al. Gynecol Oncol. 2004 Oct;95(1):165-72. doi: 10.1016/j.ygyno.2004.06.029. Gynecol Oncol. 2004. PMID: 15385127 Clinical Trial.
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.
Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M, Gaglia A, Kostopoulou V, Mylonakis N, Economopoulos T, Raptis SA. Pectasides D, et al. Eur Urol. 2004 Aug;46(2):216-21. doi: 10.1016/j.eururo.2004.03.001. Eur Urol. 2004. PMID: 15245816 Clinical Trial.
Codon 12 ras mutations in patients with myelodysplastic syndrome: incidence and prognostic value.
Constantinidou M, Chalevelakis G, Economopoulos T, Koffa M, Liloglou T, Anastassiou C, Yalouris A, Spandidos DA, Raptis S. Constantinidou M, et al. Ann Hematol. 1997 Jan;74(1):11-4. doi: 10.1007/s002770050248. Ann Hematol. 1997. PMID: 9031609
Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
Economopoulos T, Fountzilas G, Dimopoulos MA, Papageorgiou S, Xiros N, Kalantzis D, Dervenoulas J, Raptis S. Economopoulos T, et al. Eur J Haematol. 2003 Oct;71(4):257-62. doi: 10.1034/j.1600-0609.2003.00151.x. Eur J Haematol. 2003. PMID: 12950234 Clinical Trial.
205 results
Jump to page